Ally Bridge Group (Ny) LLC Context Therapeutics Inc. Transaction History
Ally Bridge Group (Ny) LLC
- $141 Million
- Q3 2024
A detailed history of Ally Bridge Group (Ny) LLC transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 1,757,524 shares of CNTX stock, worth $1.79 Million. This represents 2.45% of its overall portfolio holdings.
Number of Shares
1,757,524
Previous 1,886,232
6.82%
Holding current value
$1.79 Million
Previous $3.77 Million
8.7%
% of portfolio
2.45%
Previous 3.54%
Shares
4 transactions
Others Institutions Holding CNTX
# of Institutions
45Shares Held
56.9MCall Options Held
0Put Options Held
0-
Deep Track Capital, LP Greenwich, CT7.42MShares$7.57 Million0.54% of portfolio
-
Nextech Invest Ag7.42MShares$7.57 Million2.37% of portfolio
-
Avidity Partners Management LP Dallas, TX7.42MShares$7.57 Million0.89% of portfolio
-
Great Point Partners LLC Greenwich, CT6.93MShares$7.07 Million6.28% of portfolio
-
Blue Owl Capital Holdings LP New York, NY5.41MShares$5.52 Million3.5% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $16.3M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...